Concepedia

Kenji Nakahara

KN

Statistics

Publications

17

Citations

983

H-Index

14

Active since

2006

Affiliations

The University of Osaka(Current)

Shionogi (Japan)

Futaba (Japan)

Janssen (Belgium)

Hokkaido University

Kenji Nakahara is an author at The University of Osaka specializing in chemistry, natural sciences, and organic synthesis.

ORCID

Publications per year

2006–2025

17

Publications

17

Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19

Yuto Unoh, Shota Uehara, Kenji Nakahara et al. · Journal of Medicinal Chemistry · 2022 · 590 citations · Full text

, , +15

Discovery of S-217622, a Non-Covalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19

Yuto Unoh, Shota Uehara, Kenji Nakahara et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2022 · 56 citations · Full text

, , +13

Structure-Based Design of Selective β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: Targeting the Flap to Gain Selectivity over BACE2

Kazuki Fujimoto, Eriko Matsuoka, Naoya Asada et al. · Journal of Medicinal Chemistry · 2019 · 40 citations · Full text

, , +17

Discovery of Potent and Centrally Active 6-Substituted 5-Fluoro-1,3-dihydro-oxazine β-Secretase (BACE1) Inhibitors via Active Conformation Stabilization

Kenji Nakahara, Kouki Fuchino, Kazuo Komano et al. · Journal of Medicinal Chemistry · 2018 · 34 citations · Full text

, , +17

New Perspective for Natural Products Synthesis:  Concise Synthesis of (+)-Sch 642305 by Chiral Auxiliary Multiuse Methodology

Hiromichi Fujioka, Yusuke Ohba, Kenji Nakahara et al. · Organic Letters · 2007 · 31 citations

, , +11

1–5 of 17